Total Payments
$93,017
2024 Payments
$2,580
Companies
44
Transactions
1,642
Medicare Patients
12,767
Medicare Billing
$615,874
Payment Breakdown by Category
Research$73,930 (79.5%)
Food & Beverage$17,381 (18.7%)
Travel$1,407 (1.5%)
Education$299.48 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $73,930 | 599 | 79.5% |
| Food and Beverage | $17,381 | 1,027 | 18.7% |
| Travel and Lodging | $1,407 | 2 | 1.5% |
| Education | $299.48 | 14 | 0.3% |
Payments by Type
Research
$73,930
599 transactions
General
$19,087
1,043 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| BIOTRONIK INC. | $76,098 | 626 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $2,447 | 175 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,937 | 149 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,386 | 62 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $1,155 | 73 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,035 | 58 | $0 (2024) |
| Abbott Laboratories | $1,005 | 39 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $931.10 | 67 | $0 (2024) |
| Amgen Inc. | $926.78 | 54 | $0 (2024) |
| PFIZER INC. | $688.22 | 52 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,580 | 121 | Novartis Pharmaceuticals Corporation ($385.33) |
| 2023 | $2,144 | 108 | Novartis Pharmaceuticals Corporation ($256.31) |
| 2022 | $1,968 | 130 | Novartis Pharmaceuticals Corporation ($336.03) |
| 2021 | $2,571 | 149 | AstraZeneca Pharmaceuticals LP ($403.06) |
| 2020 | $1,928 | 118 | AstraZeneca Pharmaceuticals LP ($378.79) |
| 2019 | $18,175 | 293 | BIOTRONIK INC. ($16,166) |
| 2018 | $32,095 | 384 | BIOTRONIK INC. ($30,140) |
| 2017 | $31,557 | 339 | BIOTRONIK INC. ($29,536) |
All Payment Transactions
1,642 individual payment records from CMS Open Payments — Page 1 of 66
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $11.44 | General |
| Category: Cardiology | ||||||
| 12/17/2024 | Abbott Laboratories | AMPLATZER AMULET (Device) | Food and Beverage | In-kind items and services | $122.71 | General |
| Category: Structural Heart | ||||||
| 11/28/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $8.97 | General |
| Category: Cardiology | ||||||
| 11/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $27.24 | General |
| Category: DIABETES | ||||||
| 11/21/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $24.60 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/19/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $16.65 | General |
| Category: Cardiovascular | ||||||
| 11/19/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $13.24 | General |
| Category: Cardiology | ||||||
| 11/18/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: Cardiology | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/13/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: Not Applicable | ||||||
| 11/13/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $6.09 | General |
| Category: Cardiology | ||||||
| 11/08/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $22.79 | General |
| Category: Cardiovascular | ||||||
| 11/08/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $15.19 | General |
| Category: Cardiology | ||||||
| 11/06/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $17.65 | General |
| Category: Cardiology | ||||||
| 11/05/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $31.36 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/31/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/30/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $10.12 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/29/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $30.41 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/25/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $25.03 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/24/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $18.85 | General |
| Category: Cardiology | ||||||
| 10/23/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $27.31 | General |
| Category: Cardiovascular | ||||||
| 10/22/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $22.11 | General |
| Category: Cardiology | ||||||
| 10/14/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: Cardiology | ||||||
| 10/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: DIABETES | ||||||
| 10/09/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $10.88 | General |
| Category: Cardiovascular | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Protego DF4 | BIOTRONIK INC. | $45,598 | 257 |
| Plexa | BIOTRONIK INC. | $28,333 | 342 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 2,590 | 3,277 | $459,578 | $127,185 |
| 2022 | 25 | 3,004 | 3,767 | $504,258 | $146,623 |
| 2021 | 26 | 3,784 | 4,730 | $583,762 | $173,073 |
| 2020 | 24 | 3,389 | 4,277 | $541,108 | $168,993 |
Total Patients
12,767
Total Services
16,051
Medicare Billing
$615,874
Procedure Codes
101
All Medicare Procedures & Services
101 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 280 | 312 | $88,152 | $31,598 | 35.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 215 | 341 | $51,423 | $21,459 | 41.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 207 | 265 | $58,035 | $21,344 | 36.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 349 | 352 | $73,568 | $17,450 | 23.7% |
| 33208 | Insertion of pacemaker and upper and lower heart chamber electrode | Facility | 2023 | 14 | 14 | $33,053 | $6,081 | 18.4% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 73 | 231 | $23,793 | $4,083 | 17.2% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 88 | 285 | $24,795 | $3,958 | 16.0% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 242 | 243 | $18,711 | $3,422 | 18.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 379 | 425 | $14,025 | $2,739 | 19.5% |
| 93272 | Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | Facility | 2023 | 136 | 139 | $9,591 | $2,433 | 25.4% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 25 | 28 | $9,912 | $2,289 | 23.1% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 233 | 234 | $13,104 | $2,218 | 16.9% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 17 | 55 | $10,010 | $1,417 | 14.2% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 11 | 12 | $5,508 | $947.32 | 17.2% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Facility | 2023 | 46 | 46 | $3,266 | $925.37 | 28.3% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 37 | 38 | $3,990 | $837.51 | 21.0% |
| 93350 | Ultrasound of heart during rest, exercise and/or drug-induced stress with report | Facility | 2023 | 20 | 20 | $4,480 | $829.12 | 18.5% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Facility | 2023 | 59 | 62 | $4,712 | $815.56 | 17.3% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 17 | 19 | $1,577 | $765.51 | 48.5% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 56 | 61 | $2,902 | $637.45 | 22.0% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2023 | 28 | 31 | $1,550 | $426.87 | 27.5% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 19 | 21 | $1,701 | $408.24 | 24.0% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 39 | 43 | $1,720 | $101.05 | 5.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 288 | 328 | $91,624 | $34,196 | 37.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 226 | 271 | $57,181 | $22,847 | 40.0% |
About Dr. Robert Lutan, MD
Dr. Robert Lutan, MD is a Cardiovascular Disease healthcare provider based in Saint Louis, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/25/2005. The National Provider Identifier (NPI) number assigned to this provider is 1528051422.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Lutan, MD has received a total of $93,017 in payments from pharmaceutical and medical device companies, with $2,580 received in 2024. These payments were reported across 1,642 transactions from 44 companies. The most common payment nature is "" ($73,930).
As a Medicare-enrolled provider, Lutan has provided services to 12,767 Medicare beneficiaries, totaling 16,051 services with total Medicare billing of $615,874. Data is available for 4 years (2020–2023), covering 101 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Cardiovascular Disease
- Location Saint Louis, MO
- Active Since 08/25/2005
- Last Updated 03/28/2022
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1528051422
Products in Payments
- Protego (Device) $45,598
- Plexa (Device) $28,333
- ENTRESTO (Drug) $2,109
- XARELTO (Drug) $1,937
- ELIQUIS (Drug) $1,347
- LifeVest (Device) $931.10
- BRILINTA (Drug) $777.16
- JARDIANCE (Drug) $761.51
- VERQUVO (Drug) $655.31
- FARXIGA (Drug) $532.15
- MULTAQ (Drug) $513.79
- Repatha (Biological) $510.46
- Assure WCD (Device) $447.74
- Veltassa (Drug) $425.83
- Corlanor (Drug) $399.33
- LEQVIO (Drug) $338.24
- Vascepa (Drug) $297.74
- LEXISCAN (Drug) $293.29
- Cardiac Monitoring Suite (Device) $268.61
- AMPLATZER AMULET (Device) $258.63
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Saint Louis
Dr. Jasvindar Singh, Md, MD
Cardiovascular Disease — Payments: $883,337
Cardiovascular Disease $883,337
Dr. Harvey Serota, M.d, M.D
Cardiovascular Disease — Payments: $730,638
Cardiovascular Disease $730,638
Dr. Daniel Kelly, Md, MD
Cardiovascular Disease — Payments: $538,763
Cardiovascular Disease $538,763
Dr. Alan Zajarias, Md, MD
Cardiovascular Disease — Payments: $195,866
Cardiovascular Disease $195,866
Dr. George Kichura, M.d, M.D
Cardiovascular Disease — Payments: $194,189
Cardiovascular Disease $194,189
Dr. Anish Thomas, M.d, M.D
Cardiovascular Disease — Payments: $189,906
Cardiovascular Disease $189,906